MPN Awareness Day: Turning Uncertainty into Understanding

For many people, an MPN diagnosis begins with questions: Do I have cancer? What does this mean for my future? Will I still be able to work, travel, have children, or live the life I had planned?

After diagnosis patients suddenly find themselves facing a chronic disease that may affect every aspect of their lives, yet looks different for every individual. Understanding the disease and learning how to live with it becomes the first challenge. That challenge is precisely why awareness matters: it can turn uncertainty into understanding.

On the occasion of MPN Awareness Day, AOP Health is highlighting the importance of understanding and dialogue around these rare blood cancers. Through its German-language podcast series “Ab jetzt ist alles anders? Leben nach und mit einer schwerwiegenden Diagnose” (“From Now On, Everything Is Different?”) and the newly published booklet summarizing its key insights, the company aims to provide guidance for patients, caregivers and healthcare professionals alike.

Living with more than a disease

As Elisabetta Abruzzese MD, PhD, hematologist at S. Eugenio University Hospital in Rome, says:

The burden is often invisible. Fatigue, itching, night sweats or emotional distress may not be obvious to others, yet they can profoundly affect daily life. Patients frequently report feeling misunderstood, precisely because they may look healthy on the outside. Abruzzese stresses that families, caregivers, healthcare professionals and society all have an important role to play in recognizing these hidden challenges.

The power of understanding

Peter Löffelhardt, who has been living with MPN himself for decades, is founder and president of the Global MPN Scientific Foundation. For him, information is one of the most powerful tools patients can have. "A well-informed patient is half cured," he says.

Understanding the disease, its possible progression and available treatment options can reduce fear and give patients a sense of control. Knowledge turns uncertainty into something manageable and empowers people to take an active role in decisions about their health and quality of life.

Löffelhardt is also passionate about increasing awareness of MPN as an often invisible disease.

Shared decisions

If understanding is the first step, meaningful dialogue is the next.

For Professor Dr. Martin Griesshammer, medical director at the Johannes Wesling University Clinic in Minden, Germany, modern MPN care requires physicians to listen carefully and treat every patient as an individual. Treatment decisions are no longer simply made for patients: they are made together with patients, taking into account their goals, preferences and everyday realities. Respect, trust and communication become as important as clinical expertise.

From fear to hope

“At diagnosis, many patients immediately fear the worst.” says Professor Dr. Haifa Kathrin Al-Ali, hematologist and director of the cancer center at the University Hospital Halle, Germany. "When patients hear the diagnosis, they often ask: ‘Do I have cancer? When am I going to die?’" she explains. Her response is clear:

For Al-Ali, patient empowerment begins with education. "If you don't know your enemy, it's easy to be afraid. But once you understand what you're dealing with, you know what you can do." Advances in diagnostics, new treatment options and stronger patient communities are transforming the outlook for people living with MPN. Her message for the future is simple: "The future should be filled with hope, not fear."

Turning uncertainty into understanding

Whether it is helping people cope with uncertainty after diagnosis, recognizing the impact of invisible symptoms, involving patients in treatment decisions, or giving them the confidence to shape their own future, understanding remains the foundation of better care.

That is the idea behind the German-language podcast series “Ab jetzt ist alles anders? Leben nach und mit einer schwerwiegenden Diagnose” (“From Now On, Everything Is Different?”) and the accompanying booklet released for MPN Awareness Day: providing reliable information, practical guidance and real-world perspectives that help patients move from fear to knowledge, from uncertainty to understanding.

About AOP Health

AOP Health is a global pharmaceutical health care group with roots in Austria, where the headquarters of AOP Orphan Pharmaceuticals GmbH ("AOP Health") is located. Since 1996, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine. The group has established itself internationally as a pioneer in integrated therapy solutions and operates worldwide through subsidiaries, representations, and a strong network of partners. With the claim "Needs. Science. Trust." the AOP Health Group emphasizes its commitment to research and development, as well as the importance of building relationships with physicians and patient advocacy groups to ensure that the needs of these stakeholders are reflected in all aspects of the company’s actions. (aop-health.com)

Press Contact.

Mag. Nina Roth, MAS

Head of Corporate Communications
nina.roth[at]aop-health.com

Photocredit Stock-Photo: AdobeStock_911369203
Photocredit Portraits: AOP Health/TV Salon